MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty

por Hromadka, Milan, Motovska, Zuzana, Hlinomaz, Ota, Kala, Petr, Tousek, Frantisek, Jarkovsky, Jiri, Beranova, Marketa, Jansky, Pavel, Svoboda, Michal, Krepelkova, Iveta, Rokyta, Richard, Widimsky, Petr, Karpisek, Michal
Publicado 2021

The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy

por Simek, Stanislav, Motovska, Zuzana, Hlinomaz, Ota, Kala, Petr, Hromadka, Milan, Knot, Jiri, Varvarovsky, Ivo, Dusek, Jaroslav, Rokyta, Richard, Tousek, Frantisek, Svoboda, Michal, Vodzinska, Alexandra, Mrozek, Jan, Jarkovsky, Jiri
Publicado 2020

Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial

por Hlinomaz, Ota, Motovska, Zuzana, Knot, Jiri, Miklik, Roman, Sabbah, Mahmoud, Hromadka, Milan, Varvarovsky, Ivo, Dusek, Jaroslav, Svoboda, Michal, Tousek, Frantisek, Majtan, Bohumil, Simek, Stanislav, Branny, Marian, Jarkovský, Jiří
Publicado 2021